As of July 14, 2026, Cognition Therapeutics, Inc. (CGTX) has a DilutionWatch DilutionScore of 46/100, rated MEDIUM dilution risk. Cognition Therapeutics, Inc. has a market capitalization of $105.61M, 89.50M shares outstanding, 75 institutional holders tracked. Key dilution vectors include approximately 15 months of cash runway.
Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.
📊 Score Breakdown
🔄Convertible Debt—
🌦️ Dilution Forecast
⛅
Watch
Minor dilution signals detected
19%
🔄 Reverse Split
30%
• 50-day avg $1.11 approaching $1 threshold
🔁 Convertible Conversion
15%
• Convertible debt present: 11.8% potential dilution
💹 Market Data
Market Cap$105.61M
Shares Outstanding89.50M
Float81.85M
Cash$31.13M
Debt$638.0K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 4.7% shares (2026Q1 vs prior)
75 institutional holders · 24.65M shares
#1
VANGUARD CAPITAL MANAGEMENT LLC
6.00M shares
#2
BIOS Capital Management, LP
6.00M shares
#3
DAVENPORT & Co LLC
2.89M shares
📉 Short Interest
Short Interest7.07M
Days to Cover2.2
% of Float8.6%
FINRA data as of Jun 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Jul 07, 2026
xbrl
XBRL CONVERTIBLE
Dec 31, 2021
4
INSIDER TRANSACTION
Feb 18, 2026
4
INSIDER TRANSACTION
Feb 18, 2026
4
INSIDER TRANSACTION
Feb 18, 2026
Full SEC filing analysis available with free account
→
📰 Recent News
No recent news
📋 What This Means for CGTX Shareholders
Cognition Therapeutics, Inc. (CGTX) has a DilutionScore of 46/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.
Cash runway is a key watch item: CGTX has approximately 15 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.
DilutionWatch tracks over 25 SEC filing types for CGTX in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CGTX alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.
Track CGTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CGTX — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
🔬 More Research for CGTX
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.